All in all, the research on the link between RBP4 and NAFLD is still controversial, and it is necessary to conduct more large-scale clinical and basic studies to elucidate whether NAFLD promotes or inhibits RBP4 expression, and whether RBP4 has a distinct role in specific hepatic lesions. This evidence concerns the gene RBP4 and metabolic dysfunction-associated steatotic liver disease.